Exhaustive Guide to Percutaneous Medication Administration

Overview of Percutaneous Administration

  • Percutaneous administration refers to the delivery of medications or fluids through the skin or mucous membranes for localized or systemic absorption.

  • This route includes various delivery methods:

    • Topical applications (creams, lotions, ointments).

    • Transdermal patches.

    • Inhalations.

    • Mucosal instillations (e.g., eye, ear, or vaginal drops).

  • Primary Goal: The primary objective is to achieve therapeutic effects while minimizing systemic side effects.

Characteristics of Topical Dosage Forms: Creams, Lotions, and Ointments

  • Creams

    • Defined as semisolid emulsions containing medicinal agents for external application.

    • Key characteristics: Generally non-greasy and can be removed easily with water.

    • Common application: Often used as moisturizing agents.

  • Lotions

    • Defined as aqueous (water-based) preparations containing suspended medicinal materials.

    • Key characteristics: Used as soothing agents to protect the skin and relieve rashes or itching; some have a cleansing action.

    • Administration technique: To prevent increased circulation and further itching, lotions should be gently but firmly patted onto the skin rather than rubbed.

    • Important instruction: Shake all lotions thoroughly immediately before application and use sparingly to avoid waste.

  • Ointments

    • Defined as semisolid preparations of medicinal substances in an oily base (e.g., lanolin or petrolatum).

    • Key characteristics: Can be applied to skin or mucous membranes; generally cannot be removed easily with water.

    • Function: The oily base helps maintain the medicinal substance in prolonged contact with the skin.

Clinical Procedure for Applying Creams and Ointments

  • Pre-application Checks

    • Check the Medication Administration Record (MAR) chart to confirm the correct medication name and dose.

    • Confirm the identity of the person receiving care.

    • Check the label of the tube or tub for accuracy.

    • Check the expiry date and ensure the medication is in good condition (not contaminated).

    • Note the date of opening on the tube or tub; creams should be used within 33 months of first use or as directed by the label/leaflet.

  • Application Steps

    • Wash and dry hands thoroughly before applying gloves.

    • Apply to clean skin: Wash, rinse, and dry the affected area first.

    • Exception: If the skin is very dry or flaking, apply the medication while the skin is still damp.

    • Dispensing:

    • Tubs: Scoop a small amount using a gloved hand or a clean spoon/spatula (do not put hands directly in the tub to prevent infection).

    • Tubes: Squeeze a small amount into the hand.

    • Communication: Inform the patient that the initial application may feel cold.

    • Technique: Apply a small amount gently in the direction of hair growth using a gloved hand. Do not rub vigorously.

    • Steroid-specific: Medicated creams (steroids/ointments) must be applied sparingly and only to affected areas.

    • Emollient-specific: Can usually be applied more plentifully.

    • Disposal and Hygiene: Do not return unused cream to the tub (prevents contamination). Dispose of gloves and perform hand hygiene.

    • Documentation: Document the administration as required.

    • Safety Rule: Never apply a cream prescribed for one person to another person.

Emollient Creams and Infection Control

  • Emollients are moisturizing treatments that reduce water loss by covering the skin with a protective film.

  • Used for dry or scaly conditions like eczema and psoriasis.

  • They often come in large tubes, tubs, or pump dispensers and should be applied frequently throughout the day, even if the skin is improving.

  • Application to hairy areas: Follow the direction of hair growth.

  • To prevent infection in tubs: Never put hands in the tub; use a clean spoon or spatula to scoop out the cream.

Topical Corticosteroids and the Fingertip Unit (FTU)

  • Topical Steroids must be applied very thinly and only as prescribed (typically 11 or 22 times daily) to minimize systemic absorption.

  • The Fingertip Unit (11 FTU) is a standard measure for application thinness:

    • Definition: The distance from the tip of an adult index finger to the first crease of the finger.

    • Coverage: 11 FTU is sufficient to cover an area twice the size of a flat adult hand (fingers together).

  • Recommended FTU Dosages for Adults (Single Application)

    • Genitalia: 0.50.5 FTU

    • Per hand: 11 FTU

    • Face and Neck: 2.52.5 FTU

    • Per foot: 22 FTU

    • Per arm: 33 FTU

    • Per leg: 66 FTU

    • Chest and Abdomen: 77 FTUs

    • Back and Buttocks: 77 FTUs

Topical Steroid Potency Classification

  • Mild: Hydrocortisone (0.5%0.5\% or 1%1\%).

  • Moderate: Clobetasone butyrate (0.05%0.05\%); Trimovate (combined with antimicrobial).

  • Potent: Betamethasone (0.1%0.1\%); Betnovate C (with antimicrobial); Fucidin H (Hydrocortisone with antimicrobial).

  • Very Potent: Clobetasol propionate (0.05%0.05\%); Dermovate NN (with antimicrobial).

Nitroglycerin Ointment Administration

  • Overview: A topical nitrate used to prevent and relieve angina pectoris (chest pain). It is systemically absorbed through the skin into the bloodstream.

  • Composition: Commonly available as Nitroglycerin USP 0.2%w/w0.2\%\,w/w in an ointment base (30g30\,g tube).

  • Mechanism of Action:

    • Nitroglycerin is converted into Nitric Oxide (NONO) in vascular smooth muscle cells.

    • Results in relaxation of vascular smooth muscle, causing: Predominant vasodilation of veins, reduced venous return (preload), reduced myocardial oxygen demand, and mild dilation of coronary arteries.

  • Contraindications:

    • Allergy to nitrates, severe hypotension, cardiogenic shock, severe anemia, increased intracranial pressure, recent head injury, constrictive pericarditis, or hypertrophic obstructive cardiomyopathy.

    • PDE-5 Inhibitors: Concurrent use with Sildenafil, Tadalafil, or Vardenafil is a medical emergency due to the risk of profound hypotension.

  • Administration Procedure:

    • Safety: Always wear gloves (the medication is absorbed through the skin; failure to do so causes headaches/dizziness for the nurse).

    • Assessment: Verify vital signs (BP, HR); do not administer if BP is below parameters. Assess chest pain intensity (0100-10 scale).

    • Removal of Old Dose: Wipe off all old ointment before applying a new dose to prevent overdose.

    • Site Selection: Clean, dry, hairless, intact area (upper chest, upper arm, shoulder, or back). Rotate sites.

    • Measurement: Squeeze the prescribed amount (ordered in inches or centimeters) onto the applicator paper.

    • Application: Place the paper against the skin. Do NOT rub or massage the ointment into the skin, as this alters absorption.

    • Securement: Tape the paper in place or use a transparent dressing.

  • Adverse Effects: Headache, orthostatic hypotension, flushing, reflex tachycardia, and skin irritation.

Transdermal Patch Administration

  • Definition: A medicated adhesive patch delivering medication through the skin into the bloodstream over a prolonged period (11 to 77 days).

  • Examples: Nitroglycerin, Fentanyl, Nicotine, Clonidine, Rivastigmine, Hormone Replacement Therapy, Tulobuterol.

  • Mechanisms:

    • Membrane-controlled: Porous membrane controls drug flow from a liquid/gel reservoir.

    • Matrix: Medicine is embedded in adhesive layers; body heat melts it for absorption.

  • System Layers:

    1. Occlusive backing membrane (protection).

    2. Drug reservoir or matrix.

    3. Release liner (removed before use).

    4. Adhesive layer (peripheral or face adhesive).

  • Advantages vs. Disadvantages:

    • Advantages: Avoids GIT absorption issues, avoids first-pass hepatic metabolism, improved compliance, maintains therapeutic levels for days, allows rapid termination.

    • Disadvantages: Daily dose limit (10mg10\,mg maximum), local irritation, high blood level requirements are unsuitable, sweat/heat affects adhesion, expensive.

  • Nursing Responsibilities and Steps:

    • Patient Safety: Avoid heat sources (heating pads, hot tubs, direct sun) which increase absorption and cause toxicity.

    • Removal: Peel off the old patch, fold it in half with sticky sides together, and dispose of it in a closed trash container.

    • Site Preparation: Select a clean, hairless, intact area. Clean with warm water or clear non-lotion soap. Dry completely—never apply to wet skin.

    • Application: Peel the liner (avoiding the adhesive with fingers). Press firmly with the palm for 1010 to 3030 seconds to ensure adhesion.

    • Caveat: Do not cut a patch unless explicitly stated by the manufacturer.

Wound Dressings: Types and Applications

  • Gauze Dressing: Absorbent for minor wounds and basic protection.

  • Non-adherent Dressing (e.g., Telfa): For delicate wounds/burns; prevents sticking.

  • Transparent Film (e.g., OpSite, Tegaderm): Waterproof; allows wound observation; used for superficial wounds or IV sites.

  • Hydrocolloid (e.g., DuoDERM): Gel-forming; maintains a moist environment for pressure ulcers (moderate exudate).

  • Hydrogel: Hydrates dry wounds; used for necrotic wounds or burns.

  • Foam Dressing: Highly absorbent; provides cushioning for heavy exudate.

  • Alginate Dressing (e.g., AlgiDERM, Kaltostat): Manufactured from seaweed; very absorbent for bleeding or heavily exudative/infected wounds.

  • Antimicrobial Dressing: Contains silver or iodine to reduce bacterial load.

  • General Principles for Dressing Changes:

    • Use aseptic (clean) technique.

    • Assess for signs of infection: Increased redness, swelling, warmth, pain, foul odor, or fever.

    • Document: Type, size, drainage amount, wound appearance, and patient response.

Allergy Patch Testing

  • Purpose: A diagnostic procedure for identifying substances causing allergic contact dermatitis (delayed hypersensitivity reaction appearing 2424 to 7272 hours after exposure).

  • Tested Substances: Adhesives, fragrances, metals (nickel/gold), preservatives, plastics, rubber, and topical medications.

  • The 55-Day Procedure Cycle:

    • Day 11 (Application): Small amounts of allergens are applied to the upper back in adhesive patches. Each is numbered and the skin is marked.

    • Day 33 (First Reading): Patches are removed. The provider examines the skin for erythema (redness), edema (swelling), papules (bumps), or vesicles (blisters). Skin is re-marked.

    • Day 55 (Final Reading): The provider assesses for delayed reactions. Results are recorded as negative, doubtful, positive (red/raised), or strong positive (blisters).

  • Patient Instructions: Keep the area dry (no bathing/swimming/sweating), do not scratch, leave markings intact, and wear loose clothing to reduce friction.